coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Garden City PCN, Dartford · Health Inequalities Profile

    PCN U04973 · NHS Kent and Medway Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    62,572

    Registered population

    60.3% aged 18–64

    14.7%

    Aged 65+

    ICB 19.9% · England 17.9%

    23.7%

    Ethnic minority (non-White)

    9.3% Asian · England 9.6%

    10.2%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~5,226

    Core20 residents (est.)

    Resident basis; registered basis ~6,416 · see page 3

    8,287

    Hypertension register

    +9.32% in 3 yrs · England +5.60%

    392

    SMI register

    35.4% of Dartford's

    932

    COPD register

    Reviews -10.30% in 3 yrs

    Forecast to 2030

    11,586

    Hypertension patients, 2030

    +3,299 on today

    68.8%

    QRISK ≥20% on statins, 2030

    +5.39pp over 3 yrs

    3.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    14.9 pp
    Core20 deprivation is concentrated in two practices.

    Practice Core20 shares span 14.9 pp: Swanscombe Health Centre has 14.9% (5,591 estimated patients), Pilgrims Way Surgery 9.0% (825), and Downs Way Medical Practice.

    -8.5%
    Asthma annual review coverage fell over three years.

    Asthma review coverage is 67.0% (about 910 unreviewed), having fallen 8.5% over 2023 to 2025 against England (+4.4%), which may reflect recall strain.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Projected list growth of 13.3% coincides with a young demographic and diverse communities

    Garden City PCN registers 62,572 patients, with 25.0% aged 0-17 against 23.3% in Dartford, 20.7% in NHS Kent and Medway ICB, and 19.6% in England. Those aged 65+ represent 14.7% (Dartford 15.1%, ICB 19.9%, England 17.9%). Associated Census usual residents show a 23.7% ethnic minority share, including 9.3% Black residents (Dartford 10.5%, ICB 3.1%, England 4.2%), rather than registered-patient ethnicity. Practice-area Black resident shares span from 14.3% at Pilgrims Way Surgery to 2.1% at Downs Way Medical Practice. Unverified product forecasts project 13.3% list growth to 2030 (Dartford 9.1%, ICB 6.0%, England 2.3%).

    Age profile

    0–1725.0%
    18–6460.3%
    65+14.7%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White76.3%
    Asian9.3%
    Black9.3%
    Mixed3.0%
    Other2.1%

    Older people · falls rows are Dartford local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Dartford LA)2,0062,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.9%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.5%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Dartford LA)1,0009819552024/25
    Falls deaths, all ages, per 100,000 (Dartford LA)14.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation averages decile 6.0 overall but practice Core20 shares vary across 14.9 pp

    Garden City PCN averages IMD decile 6.0 (Dartford 6.0, NHS Kent and Medway ICB 5.4, England 5.5) with a 10.2% Core20 registered share, above Dartford (9.8%) but below NHS Kent and Medway ICB (17.1%) and England (21.0%). Practice shares span 14.9 pp: Swanscombe Health Centre records 14.9% (5,591 estimated patients) and Pilgrims Way Surgery 9.0% (825), whereas Downs Way Medical Practice records 0.0%. Practice estimates sum to 6,416 registered patients against 5,226 associated residents in deciles 1 and 2. Reconciling these count bases ensures outreach targets the highest-need practices effectively.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Swanscombe14.9% · 5,591 patients
    Pilgrims Way9.0% · 825 patients
    Downs Way Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    392

    SMI register

    0.64% recorded prevalence

    247

    Learning disability register

    0.40% recorded prevalence

    18

    Care homes, 725 beds

    In the PCN catchment

    8.6%

    Provide unpaid care

    Dartford, Census 2021

    Recorded learning disability prevalence is 0.4% (247 patients) and severe mental illness is 0.6% (392 patients), both below Dartford, ICB, and England rates (0.6% for learning disability; 0.8%, 0.9%, and 1.0% for mental illness). The catchment includes 18 care homes with 725 beds, though capacity does not establish registered residency. Lower recorded prevalence may reflect diagnostic variation, unverified locally and testable by practice register audits.

    Severe mental illness: physical health checks

    SMI recorded prevalence is 0.6% (England 1.0%). Annual physical checks trail England across individual elements: blood pressure checks reached 75.5% (England 83.4%) and BMI recording 72.6% (England 82.1%). Routine physical monitoring requires systematic recall across all check components.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,287

    Hypertension register

    +9.32%

    Register growth, 3 yrs

    Dartford +7.12% · England +5.60%

    −3.17pp

    BP control, under 80

    ≤140/90 · −0.16pp aged 80+

    +3,299

    More patients by 2030

    Forecast 11,586 (16.20%)

    Hypertension case-finding and control

    The hypertension register numbers 8,287 patients, representing 13.6% recorded prevalence, below England (15.2%), Dartford (15.9%) and NHS Kent and Medway ICB (16.2%). Although the register grew +9.3% over 2023 to 2025 (England +5.6%), recent blood pressure checks stand at 84.8% (England 90.0%; 3-year change -2.8% vs England +3.6%). Furthermore, blood pressure control in patients aged under 80 stands at 63.5% (3-year change -4.8% vs England +3.2%; England 67.8%), ranging across practices from 61.9% at Swanscombe Health Centre and 62.6% at Pilgrims Way Surgery to 67.9% at Downs Way Medical Practice. Blood pressure monitoring and clinical control lag national rates, indicating an opportunity to prioritise systematic recall and home monitoring for under-controlled patients.

    Lipids and statins

    Lipid-lowering therapy reaches 56.3% of patients with QRISK ≥ 20%, below England (63.6%) and Dartford (64.2%). Statin coverage in diabetes without cardiovascular disease also lags at 67.1% (England 73.2%). Fewer at-risk patients receive primary prevention lipid therapy than nationally, pointing to a clear need to prioritise proactive cardiovascular risk reviews.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202687,577£1.50£1.90£1.86£131,366
    Cardiovascular (all), 2025125,431£3.36£3.57£3.33£421,448

    In 2026, the PCN prescribed 87,577 lipid-regulating drug items at £1.50 per item, below England (£1.86), Dartford (£1.79) and NHS Kent and Medway ICB (£1.90), spending £31,528 less than at England's unit cost. Unit costs sit below national levels, suggesting clinical teams can prioritise closing initiation gaps in high-risk patients over expenditure controls.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −8.54%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.95%

    Asthma prevalence, PCN 3-yr % change

    Asthma recorded prevalence is 4.9% (2,773 patients) and COPD is 1.5% (932 patients), both below England (6.6% and 1.9%). While asthma annual review coverage is 67.0% (England 65.7%), three-year change was -8.5% over 2023 to 2025 (England +4.4%), leaving about 910 patients without a recorded review. COPD reviews reached 68.9% (England 76.4%), with three-year change of -10.3% (England +2.8%). Slower review rates may reflect recall strain, unverified locally, requiring prioritized clinical searches.

    Cancer register and children's immunisation

    Cancer prevalence is 3.4% (2,057 patients; England 3.8%). In Q1 2025/26 childhood immunisations, pre-school coverage trails targets: MMR dose 1 reached 90.1% at age 5 but dose 2 reached 81.7%, creating an 8.4 pp same-cohort dose difference. Pre-school 4-in-1 booster coverage is 80.2% (England 80.9%), below the 95.0% target by 14.8 pp. Scheduling gaps between primary and pre-school boosters risk unprotected cohorts entering school.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.3%

    England 91.0%

    6-in-1 complete primary course at 24 months92.7%

    England 92.2%

    MMR dose 1 at 24 months86.4%

    England 88.3%

    MMR dose 2 at age 581.7%

    England 82.8%

    4-in-1 pre-school booster at age 580.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In NHS Kent and Medway ICB, 55.6% of staged cancers (4,661 of 8,384) were diagnosed at stage 1 or 2 in 2022 (England 55.3%), with a distance of -19.4 pp to the 75.0% national ambition by 2028. Known-stage coverage was 63.6% (8,384 of 13,189; England 67.0%), representing 1,627 extra early-stage cases a year to reach 75% across the ICB; staging was not captured at PCN level. For GARDEN CITY PCN, cervical screening coverage is 68.7% (England 66.8%, ICB 69.9%), with 65.7% at Swanscombe Health Centre and 74.8% at Downs Way Medical Practice. PCN breast screening coverage is 68.0% (England 69.9%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Dartford and Gravesham NHS Trust achieved 78.1% on the 28-day faster diagnosis standard (standard 75.0%; King's College Hospital NHS Foundation Trust 80.7%, NHS Kent and Medway Integrated Care Board 76.8%, England 79.3%) and 97.5% on 31-day treatment (standard 96.0%). The 62-day referral to treatment rate was 63.6%, showing a distance of -21.4 pp to the 85.0% standard (King's College Hospital 70.1%, ICB 75.9%, England 71.2%). Diagnostic 6-week waits stood at 8.4% (England 23.1%). These provider metrics describe acute system performance rather than PCN delivery.

    Pathways within standard (%)Dartford and GraveshamKing's CollegeKent and Medway ICBEngland
    28-day faster diagnosis (75%)78.1480.6876.7879.32
    31-day treatment (96%)97.4896.6895.8492.50
    62-day referral to treatment (85%)63.5970.1575.9371.16
    Diagnostic waits over 6 weeks (%)Dartford and GraveshamKent HealthKing's CollegeEngland
    MRI0.36—21.2221.40
    CT2.08—22.609.92
    Echocardiography3.90—14.3928.48
    Colonoscopy0.40—41.8130.83
    Gastroscopy0.00—35.9829.02
    All 15 DM01 tests8.3727.4919.1523.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In June 2026, Kent recorded 210,170 community care contacts across 265,905 care activities, covering 60,605 patients. NHS Kent and Medway Integrated Care Board recorded 254,055 contacts and 297,595 activities. Community contacts with adults aged 65+ accounted for 65.8% of Kent residents' contacts (138,250). These provisional local authority and ICB figures reflect wider community activity, not PCN-level care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 18.3 pp and vaccination achievement spans 36.2 pp across practices

    In 2025/26, QOF clinical achievement reached 100.0% at Swanscombe Health Centre, 100.0% at Downs Way Medical Practice, and 99.8% at Pilgrims Way Surgery (England 97.1%). In contrast, vaccination and immunisation achievement spans a 36.2 pp range, from 16.4% at Pilgrims Way Surgery and 21.1% at Swanscombe Health Centre to 52.5% at Downs Way Medical Practice (England 55.2%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Swanscombe11114.923.0%75.8%71.4%
    Downs Way Medical1110.036.3%63.2%69.1%
    Pilgrims Way1039.041.3%71.0%61.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNDartfordAssetPCNDartford
    Care homes (catchment)18 (725 beds)n/aSchools (catchment)113n/a
    Children's centres87Places of worship5741
    Libraries77Food banks (VCS)1no data
    Homelessness support (VCS)n/a1Day centres (VCS)95
    Children and young people (VCS)11Carers support groups (VCS)n/a3
    Primary schools (LA maintained)116Primary academies2222

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall catch-up

    Asthma review coverage is 67.0% of the 2,773 register (England 65.7%), but fell 8.5% over 2023 to 2025 (England +4.4%), leaving 914 (about 910) unreviewed. For discussion: run a single-template asthma recall search with flexible review slots, starting in the highest-deprivation practices. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension control and lipid review

    On the 8,287 hypertension register (13.6% vs England 15.2%), under-80 BP control is 63.5% (England 67.8%, down 4.8% over 2023 to 2025 vs England +3.2%) and QRISK ≥ 20% lipid therapy is 56.3% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Learning disability register validation

    Recorded learning disability prevalence is 0.4% (247 patients) against 0.6% in Dartford, NHS Kent and Medway ICB, and England, a benchmark range of +106 to +121 patients (121 against England). For discussion: audit clinical records for uncoded learning disability diagnoses and review annual health check invitations. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Diverse community access review (p2)Black / African / Caribbean / Black BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness physical checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening equity outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall catch-up (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Hypertension control and lipid review (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15